Drugs / Human derived Transfer factor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02837939 | Jul 2016 → Jul 2025 | cirrhosis of liver, liver failure | Martin Janičko | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human derived Transfer factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02837939 ↗ |
| Route | Subcutaneous | “subcutaneous injection” NCT02837939 ↗ |